Overview

• Attorneys general from all 50 states, Washington D.C. and four territories signed on to a $7.4 billion deal to resolve thousands of lawsuits over Purdue Pharma’s role in the opioid crisis.
• The settlement requires $6.5 billion in payments by the Sackler family and $900 million by Purdue Pharma to be disbursed over 15 years.
• State and local governments, individuals and Native American tribes will receive funds directed toward addiction treatment, recovery and prevention programs.
• The agreement ends the Sackler family’s control of Purdue Pharma, bars them from U.S. opioid sales and installs a state-appointed board of trustees to oversee the company.
• The deal now awaits confirmation by a federal bankruptcy court, with a hearing set in the coming days and an opt-out provision allowing individual lawsuits to continue.